# FDA Inspection 1169390 - LifeShare Blood Center - April 25, 2022

Source: https://www.keypedia.com/records/fda_inspections/lifeshare-blood-center/260c495a-cdca-47de-807a-1f29b8c4e2d7
Source feed: FDA_Inspections

> FDA Inspection 1169390 for LifeShare Blood Center on April 25, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1169390
- Company Name: LifeShare Blood Center
- Inspection Date: 2022-04-25
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1169390 - 2022-04-25](https://www.keypedia.com/records/fda_inspections/lifeshare-blood-center/6649fb95-9205-49c3-bf5b-5c31c8b196a7)

Company: https://www.keypedia.com/companies/lifeshare-blood-center/abb4110e-af55-4ebb-8e54-6349fd572be7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d